Acquired Hemophilia A Developed Post COVID-19 Vaccine: An Extremely Rare Complication
Open Access
- 1 January 2022
- journal article
- research article
- Published by Elmer Press, Inc. in Journal of Medical Cases
- Vol. 13 (1) , 1-4
Abstract
Acquired Hemophilia A Developed Post COVID-19 Vaccine: An Extremely Rare ComplicationKeywords
This publication has 17 references indexed in Scilit:
- De novo acquired hemophilia as an immune dysregulation phenomenon following SARS‐CoV‐2 infectionTransfusion, 2020
- COVID-19 and the Coombs testBlood, 2020
- Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseasesClinical Immunology, 2020
- The first case of acquired hemophilia A associated with SARS‐CoV‐2 infectionAmerican Journal of Hematology, 2020
- Lupus anticoagulant is frequent in patients with Covid‐19Journal of Thrombosis and Haemostasis, 2020
- Immune Thrombocytopenic Purpura in a Patient with Covid-19New England Journal of Medicine, 2020
- Immune thrombocytopaenic purpura: an autoimmune cross-link between infections and vaccinesLupus, 2014
- Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)Journal of Thrombosis and Haemostasis, 2012
- Do proteolytic antibodies complete the panoply of the autoimmune response in acquired haemophilia A?British Journal of Haematology, 2011
- Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' OrganisationBlood, 2006